A drug formerly used to treat the skin disorder psoriasis has shown encouraging results in a phase 2 trial to assess its effectiveness in treating type 1 diabetes, according to new research published in The Lancet Diabetes & Endocrinology.

Read More:
Alefacept drug shows encouraging results in phase 2 trial for type 1 diabetes

Scroll to Top